UBS Group AG - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$524,629
-67.6%
19,029
-64.7%
0.00%
-100.0%
Q2 2023$1,620,625
+12.9%
53,913
+36.0%
0.00%0.0%
Q1 2023$1,435,976
+43.5%
39,635
+41.2%
0.00%
Q4 2022$1,000,971
+291.0%
28,062
+271.9%
0.00%
Q3 2022$256,000
+468.9%
7,545
+376.3%
0.00%
Q2 2022$45,000
-98.3%
1,584
-98.1%
0.00%
-100.0%
Q1 2022$2,707,000
-6.2%
83,764
-15.4%
0.00%0.0%
Q4 2021$2,886,000
+3463.0%
98,999
+3148.0%
0.00%
Q3 2021$81,000
-89.1%
3,048
-87.4%
0.00%
Q2 2021$744,000
-83.8%
24,143
-86.2%
0.00%
-100.0%
Q1 2021$4,585,000
+0.5%
175,149
-3.4%
0.00%0.0%
Q4 2020$4,564,000
+1204.0%
181,382
+981.6%
0.00%
Q3 2020$350,000
-50.4%
16,770
-43.6%
0.00%
Q2 2020$706,000
-3.8%
29,717
-27.2%
0.00%
Q1 2020$734,000
-42.3%
40,828
-23.8%
0.00%
Q4 2019$1,271,000
-71.7%
53,575
-67.2%
0.00%
-100.0%
Q3 2019$4,485,000
-80.5%
163,200
-76.6%
0.00%
-88.9%
Q2 2019$23,040,000
-2.8%
696,262
+2.9%
0.01%
-10.0%
Q1 2019$23,699,000
+103.3%
676,351
+92.8%
0.01%
+100.0%
Q4 2018$11,656,000
-28.3%
350,883
+8.7%
0.01%
-16.7%
Q3 2018$16,250,000
+816.5%
322,740
+989.6%
0.01%
+500.0%
Q2 2018$1,773,000
+169.9%
29,620
+106.5%
0.00%
Q1 2018$657,000
+20.3%
14,346
+4.7%
0.00%
Q4 2017$546,000
-69.3%
13,705
-69.2%
0.00%
-100.0%
Q3 2017$1,781,000
-31.8%
44,522
-26.5%
0.00%0.0%
Q2 2017$2,611,000
+37.3%
60,582
-0.3%
0.00%0.0%
Q1 2017$1,902,000
+276.6%
60,740
+203.5%
0.00%
Q4 2016$505,000
-26.2%
20,011
-27.7%
0.00%
Q3 2016$684,000
+643.5%
27,689
+513.4%
0.00%
Q2 2016$92,000
+35.3%
4,514
+0.7%
0.00%
Q1 2016$68,000
-90.3%
4,482
-91.4%
0.00%
Q4 2015$698,000
-1.0%
51,930
+3.4%
0.00%
Q3 2015$705,000
-11.7%
50,229
+6.8%
0.00%
-100.0%
Q2 2015$798,000
+47.8%
47,017
+5.4%
0.00%
Q1 2015$540,000
+95.7%
44,624
+34.6%
0.00%
Q4 2014$276,00033,1410.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders